: 19033590  [PubMed - indexed for MEDLINE]1154. Ann Thorac Surg. 2008 Dec;86(6):1982-5. doi: 10.1016/j.athoracsur.2008.04.092.Thoratec left ventricular assist device removal after toxic myocarditis.Leontiadis E(1), Morshuis M, Arusoglu L, Cobaugh D, Koerfer R, El-Banayosy A.Author information: (1)Department of Thoracic and Cardiovascular Medicine, Heart and Diabetes Center North-Rhine Westphalia, Ruhr-University of Bochum, Bad Oeynhausen, Germany.The clinical manifestation and natural history of myocarditis range is variablefrom asymptomatic stages to intractable circulatory compromise and death.Supportive therapy is paramount in the treatment of this condition. The use ofmechanical circulatory support as bridge-to-recovery or bridge-to-transplantationin cases of cardiovascular collapse is often the only therapeutic option forthese patients. We report the case of an adolescent boy with toxic myocarditis,due to cannabis abuse, who was supported with a Thoratec left ventricular assist device (Thoratec Laboratories Corp, Pleasanton, CA) for 96 days before deviceremoval.